Answer
Jun 19, 2025 - 11:36 AM
Ozanimod is a medication primarily used to treat relapsing forms of multiple sclerosis (MS) and ulcerative colitis. Its success rate can vary depending on the condition being treated and the specific metrics used to define success. Clinical trials have demonstrated its efficacy in reducing relapse rates and slowing disease progression in MS, as well as improving symptoms and maintaining remission in ulcerative colitis. For precise success rates, it is best to refer to specific clinical trial data and outcomes.
